HomeSVA • NASDAQ
add
Sinovac Biotech Ltd
Previous close
$6.47
Year range
$22.40 - $28.18
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 60.67M | -13.58% |
Operating expense | 174.35M | -8.83% |
Net income | -3.95M | -146.68% |
Net profit margin | -6.51 | -154.02% |
Earnings per share | — | — |
EBITDA | -99.97M | 42.46% |
Effective tax rate | -5.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.57B | -4.47% |
Total assets | 12.90B | -6.03% |
Total liabilities | 1.39B | -6.57% |
Total equity | 11.51B | — |
Shares outstanding | 99.64M | — |
Price to book | 0.07 | — |
Return on assets | -2.60% | — |
Return on capital | -2.83% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -3.95M | -146.68% |
Cash from operations | -219.45M | -997.49% |
Cash from investing | 218.41M | 116.00% |
Cash from financing | -85.59M | -178.83% |
Net change in cash | -100.08M | 92.42% |
Free cash flow | -78.38M | 43.61% |
About
CEO
Founded
2001
Website
Employees
3,037
